BioMarin Pharmaceutical has struck a deal to purchase fellow biotechnology firm Amicus Therapeutics for about $4.8 billion in money.
Source link
BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion
Related Posts
40 Best Cyber Monday Deals Under $100 (2025)
It is all too simple to blow via your funds throughout procuring holidays. However we at WIRED have examined loads…
Nvidia embraces AI investor, topping $40 billion in equity bets 2026
Nvidia founder and CEO, Jensen Huang, speaks in the course of the twenty ninth annual Milken Institute World Convention on…
Microsoft’s new responsible tech lead on high-speed AI development
Absolutely accountable, reliable know-how is an virtually not possible mandate in a tech panorama that prioritizes velocity — however that…